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ABSTRACT 
Aims: Prematurely born infants are at high risk of respiratory morbidity following 
neonatal unit discharge, though prediction of outcomes is challenging.  We have 
tested the hypothesis that cluster analysis would identify discrete groups of 
prematurely born infants with differing respiratory outcomes during infancy. 
Methods:  168 infants (median (IQR) gestational age 33 (31 – 34) weeks) were 
recruited in the neonatal period from consecutive births in a tertiary neonatal unit.  
The baseline characteristics of the infants were used to classify them into hierarchical 
agglomerative clusters.  Rates of viral lower respiratory tract infections (LRTIs) were 
recorded for 151 infants in the first year after birth.                                                     
Results:  Infants could be classified according to birth weight and duration of 
neonatal invasive mechanical ventilation (MV) into three clusters.  Cluster one (MV 
≤5 days) had few LRTIs.  Clusters two and three (both MV ≥6 days, but BW ≥ or 
<882g respectively) had significantly higher LRTI rates.  Cluster two had a higher 
proportion of infants experiencing respiratory syncytial virus LRTIs (p=0.01) and 
cluster three a higher proportion of rhinovirus LRTIs (p<0.001) 
Conclusions: Readily available clinical data allowed classification of prematurely 
born infants into one of three distinct groups with differing subsequent respiratory 
morbidity in infancy.   
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INTRODUCTION 
Infants born prematurely are at higher risk of lower respiratory tract infections 
(LRTIs) in infancy, which may in themselves be associated with poorer respiratory 
health.  We have shown that infants born prematurely have high rates of respiratory 
syncytial virus (RSV) LRTIs and subsequent respiratory morbidity in the first two 
years after birth 1; 2.  LRTIs related to other viral pathogens, including human 
rhinovirus (RV), may also be associated with poorer infant outcomes in those born 
prematurely 3; 4. Although the risk is elevated above that for term-born infants, LRTI 
rates of between 46% and 58% have been reported, with fewer than five per cent of 
infants requiring hospitalisation 2; 5.   
 
Prematurely born children are also at higher risk of respiratory morbidity in later 
childhood than term-born infants.  The severity of any respiratory disease and the 
healthcare burden this poses, however, varies substantially amongst children born 
prematurely.  Cohort studies have shown that while group average values for 
pulmonary function in children born prematurely were lower than those of matched 
term-born controls, many children were within the normal range 6; 7. 
 
The heterogeneity in those adverse consequences of preterm birth highlights the 
importance of being better able to prognosticate both to support clinicians in 
counselling parents in the neonatal period and to guide researchers in identifying high 
risk groups to target for interventional studies.  Prophylactic agents against respiratory 
viral infections are becoming increasingly available, but are expensive, hence 
identifying infants at highest risk for adverse outcomes is desirable.  A number of 
studies have identified risk factors for poorer outcomes following preterm birth.  We 
5 
 
have demonstrated that certain single nucleotide polymorphisms were associated with 
a higher risk of RSV LRTIs, greater respiratory morbidity in the first year after birth 
and poorer pulmonary function at one year of age 8. While undertaking genetic 
profiling is becoming both easier and less costly, such data are still not routinely 
available within clinical practice.  Other studies have identified specific risk factors 
associated with poorer outcomes, including duration of supplemental oxygen 
requirement, gestational age, sex, intrauterine growth restriction, race and socio-
demographic factors 9; 10. The data from such studies are of great epidemiological 
value, though are of less benefit to clinicians attempting to determine the prognosis of 
an individual infant.  Additionally, those studies have often focussed on the clinical 
course within the first year after birth and have not provided data on longer-term 
outcomes.  
 
The aim of the current study was to examine whether groups of phenotypically 
distinct infants (clusters) could be identified based on the detailed clinical and 
physiological data collected at baseline in a large prospectively recruited cohort of 
prematurely born infants.  Further aims were to determine whether a simplified set of 
routinely available clinical characteristics could be used to reliably classify infants 
into identified groups.  Furthermore, we aimed to determine whether such groups had 
different risk profiles for LRTIs in infancy, specifically those caused by RSV and RV.  
An exploratory analysis investigated whether there were any differences in respiratory 
outcomes between groups in a subset of the children who were followed up to school 
age. 
 
 
6 
 
METHODS 
 
Study subjects 
A cohort of 168 prematurely born infants were assessed who had been enrolled into a 
study investigating the association between premorbid lung function abnormalities 
and risk of viral LRTIs in prematurely born infants 11. They consisted of consecutive 
births outside the RSV season (defined as 1st October to 1st March) at King’s College 
Hospital NHS Foundation Trust (KCH) whose parents gave informed written consent 
for their infant’s participation in the study.  Clinical variables were recorded including 
birth weight, gestational age, days of invasive ventilation and duration of 
supplemental oxygen requirement.  Assessment of pulmonary function was made at 
36 weeks’ postmenstrual age (PMA), and comprised measurement of functional 
residual capacity by helium dilution (FRCHe) and respiratory system compliance 
(Crs) and resistance (Rrs).  Full details of the methodology for infant pulmonary 
function testing have been given elsewhere 12. All values were reported as 
standardised residuals (‘z scores’) relative to published reference data for FRCHe 13  
and Crs and Rrs 14. 
 
Throughout the first year after birth, parents were asked to contact the research team 
whenever the infant displayed signs consistent with an LRTI.  Parents also received a 
fortnightly telephone call as a reminder.  If an LRTI was reported, a researcher visited 
the infant at home or in hospital to obtain a nasopharyngeal aspirate (NPA).  NPA 
samples were tested for thirteen respiratory viruses (rhinovirus, human 
metapneumovirus, influenza A and B, parainfluenza 1-3, RSV A and B, enterovirus 
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and parechovirus via real-time reverse transcriptase polymerase chain reaction (PCR), 
and human bocavirus and adenovirus via real-time PCR).  
 
At five to seven years of age all previous participants were contacted and invited to 
return for follow-up measurements 11.  Parents gave further informed written consent 
for the child to take part in the follow up study.  Pulmonary function was assessed by 
parasternal intercostal electromyography, which provides a non-volitional measure of 
respiratory effort. We have previously shown this technique detects changes induced 
by imposition or removal of additional respiratory load in children 15; 16.  Healthcare 
utilisation was recorded and cost of care calculated.  The follow up study was granted 
ethical approval from the National Research Ethics Service Committee West 
Midlands – Coventry & Warwickshire (reference 15/WM/0117). 
 
Assessment of pulmonary function 
The parasternal intercostal electromyogram (EMGpara) was undertaken in accordance 
with published work 15. Briefly, EMGpara was recorded during ten minutes of tidal 
breathing using surface electrodes placed over the second intercostal space, directly 
adjacent to the sternum. The mean peak EMGpara per breath over the final stable 
minute of recording was reported and expressed as z scores based on previously 
reported data 15. Further details are given in the online supplementary material.  
 
Healthcare utilization and health related cost of care 
Participants’ General Practitioner (GP) records were inspected to identify any hospital 
admissions, emergency department visits, hospital outpatient appointments, other 
contacts with health professionals, GP attendances and all medication prescriptions.  
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In the United Kingdom’s National Health Service, primary care providers (General 
Practitioners) hold a comprehensive record of all healthcare contacts as they act as 
‘gatekeepers’ for all healthcare access (including secondary and specialist care by any 
medical, nursing or allied health professional).  Any visits for routine immunisations 
or health screening were not included in the analysis as these were deemed usual care.  
GP and hospital costs were calculated using the National Health Service (NHS) 
reference costing scheme 17 and medication costs using the NHS indicative costs 
listed within the British National Formulary 18. Each healthcare contact or prescription 
was classed as respiratory-related or non respiratory-related.  All healthcare costs 
were divided by the number of years of follow-up and expressed as UK pounds (£) 
per year for medication costs, hospital costs (inpatient stays, outpatient appointments 
and emergency department visits) and overall health related costs of care, with GP 
attendances expressed as number of visits per year. 
 
Statistical analysis  
The baseline characteristics of the cohort of 168 infants were used to classify them 
into clusters using hierarchical agglomerative clustering with the Euclidean distance 
metric, using Ward’s method.  Variables included in the clustering were gestational 
age, birth weight, duration of mechanical ventilation, duration of supplemental 
oxygen and z-scores for FRC, Rrs and Crs.  Gestational age, birth weight, duration of 
invasive mechanical ventilation and duration of supplemental oxygen were 
standardized prior to clustering using a nonparametric standardisation procedure (the 
median value for the column variable was subtracted from each data point and the 
result was divided by the median absolute deviation of the column variable).  The 
optimal number of clusters was selected using the majority-rule system as 
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implemented in the R package ‘NbClust’.  NbClust implements thirty cluster quality 
indices; each index provides an estimate of the optimal number of clusters in the 
dataset and the cluster number most frequently selected was used for the final 
classification 19. 
 
The clustering was visualised using a discriminant-coordinates plot, generated by 
canonical variate analysis, which projects multidimensional data into a lower 
dimensional space while preserving as much information as possible, to provide an 
easily interpretable two-dimensional representation of cluster separation and density.  
Ninety-five percent confidence regions were also derived for the clusters 20.  A 
conditional inference tree analysis was used to derive a stratification algorithm to 
predict cluster membership based on a minimal subset of input variables (R package 
“party”, version 1.1-25) 21.  Tree-based methods select variables based on their 
capacity to discriminate between categories of the response variable (in this case 
cluster number) and produce a simple decision tree which can be applied to data from 
a new subject to estimate, with optimal reliability, to which cluster the subject is most 
likely to belong.  Importantly, with a sufficiently reliable tree model, knowledge of all 
the variables used in the clustering is not required, and thus these methods may 
provide a simple-to-use tool for stratification based on readily available clinical 
measurements.  The dataset was randomly partitioned into a “training set”, 
comprising seventy-five percent of the cohort used in the cluster analysis, with the 
remaining twenty-five percent forming the “validation set”.  The training set was used 
to derive a conditional inference tree model, which was then tested using the unseen 
data from the validation set to assess the predictive accuracy of the model when 
classifying new data. 
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 Clusters were then compared using the non-parametric Kruskal-Wallis test (as the 
smaller clusters either contained too few individuals to allow for normality testing or 
demonstrated non-Gaussian distributions) post hoc testing using the Mann-Whitney 
test for differences between groups was undertaken. 
 
 
 
RESULTS 
 
A three-cluster solution was identified as optimal for the full cohort of 168 infants.   
All baseline variables were significantly different across clusters, with the exception 
of sex (Table 1). 
 
Infants could be classified with 100% accuracy into the clusters, as defined from the 
larger dataset, using a conditional inference tree (Figure 1).  All infants with a 
duration of ventilation of five days or fewer fitted cluster one.  Infants with six or 
more days of invasive ventilation were classified into cluster two or cluster three 
according to a birth weight of ≥ or < 882g respectively.   
 
First year after birth  
A total of 151 infants were followed up to one year of age.  Infants in cluster one were 
significantly less likely to have experienced any viral LRTI (p=0.02), with a 
significantly higher proportion of infants in cluster three experiencing an LRTI 
(p=0.02) (Table 2).  Infants in cluster one had a significantly higher proportion of 
infants with no LRTI (p=0.02) and a lower proportion of infants with RSV LRTI 
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(p=0.04).  Cluster two had a significantly increased proportion of infants experiencing 
RSV LRTI (p=0.01).  Infants in cluster three were significantly more likely to have 
experienced RV LRTI (p<0.001) and less likely to have had no LRTI (p=0.02) (Table 
2). 
 
School age follow up  
At school age follow-up of 56 children, the clusters comprised 45 children in cluster 
one, six in cluster two and five in cluster three.   
 
EMGpara was significantly different (p= 0.012) between groups.  Post hoc testing 
showed that median (IQR) EMGpara was significantly higher (that is worse) in 
clusters two (1.93 (1.52 to 2.01) z scores, p=0.041) and three (2.23 (1.67 to 2.86) z 
scores, p=0.014) compared to cluster one (0.99 (0.41 to 1.57) z scores). 
 
Healthcare utilisation costs, with the exception of non-respiratory related GP 
attendances and medication costs, were significantly different across clusters            
(Table 3).  Total non-respiratory related healthcare costs (p=0.002) and non-
respiratory related hospital costs (p=0.001) were significantly higher in cluster two 
than cluster one.  Total respiratory-related (p=0.001) and non-respiratory related 
healthcare costs (p=0.039), respiratory-related GP attendances (p=0.004), respiratory 
medication costs (p=0.011) and both respiratory (p=0.046) and non-respiratory related 
(p=0.036) hospital costs were significantly higher in cluster three than cluster one. 
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DISCUSSION 
 
This study has used multidimensional phenotyping based on cluster analysis to detect and 
explore distinct groups within an unselected cohort of prematurely-born infants and has 
demonstrated that the respiratory outcomes in infancy differed significantly across these 
groups.  Furthermore, exploratory analysis of data acquired at school age suggested that the 
differences persisted into childhood.  The success with which infants could be classified into 
the three clusters using readily available clinical characteristics suggests that this model could 
be of value to clinicians seeking to determine prognosis at the point of care in the neonatal 
unit.   
 
Cluster one comprised moderately and late preterm-born infants requiring minimal or no 
respiratory support in the perinatal period and with generally normal pulmonary function at 
36 weeks’ gestational age.  These infants went on to have few LRTIs in the first year after 
birth, specifically with a lower likelihood of RSV LRTI.  Pulmonary function, quantified by 
EMGpara, was within the normal range and healthcare costs over the follow-up period were 
also low.  Cluster two were generally very preterm, very low birth weight infants requiring 
respiratory support in the neonatal period.  These infants’ pulmonary function at 36 weeks 
was somewhat heterogeneous, with values ranging from normal to moderate impairment.  In 
the first year after birth this group had a higher likelihood of RSV LRTI.  Pulmonary function 
at school age appeared to be abnormal, indicated by raised EMGpara.  The only significant 
differences in healthcare costs between this cluster and cluster one were those in non-
respiratory related categories, with non-respiratory hospital costs and overall non-respiratory 
costs being higher.  Cluster three, while small, was very well-differentiated and consisted of 
infants at high risk for poor health outcomes.  The infants were born very preterm and had 
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extremely low birth weights (less than 1000 grams), required extensive respiratory support 
after birth and had significantly impaired pulmonary function at 36 weeks of gestation.  In the 
first year after birth the infants had a much higher likelihood of experiencing LRTIs, with a 
significantly larger proportion developing RV LRTIs.  At school age, they appeared to have 
raised EMGpara and high healthcare utilisation costs for respiratory problems in both primary 
and secondary care, as well as high non-respiratory related costs. 
 
The outcomes of all three clusters are of clinical as well as research interest.  An infant 
classified into cluster one could be expected to experience very little ill health in their first 
five to seven years and to have essentially normal lung function at school age.  Cluster three 
in contrast represent a high-risk group for respiratory infections in infancy and a group in 
whom high healthcare utilisation could be anticipated.  Stratifying delivery of clinical 
services in accordance with these cluster classifications may allow resources to be directed to 
those children with greatest need.  Similarly, the information we present here may support 
sample size calculations for future research studies wishing to target at risk groups for follow 
up or novel interventions. 
 
The added value of the current study to previously published data examining risk factors for 
respiratory morbidity following premature birth 7; 9; 10 is the potential for direct application to 
individual infants.  Studies often present data in terms of relative risk, whereas the decision 
metric provided here allows prediction for an infant using only their birth weight and duration 
of mechanical ventilation.  The tool can, therefore, be applied to infants in the immediate 
neonatal period.   
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Cluster analysis has been previously used to demonstrate an increased incidence of LRTIs in 
specific geographic regions 22. It has also been used to identify distinct severe bronchiolitis 
profiles 23. Our study adds to literature demonstrating using cluster analysis could be used in 
prematurely born infants to predict the likelihood of early life and school age morbidity.  
Future studies should investigate our findings in larger groups of infants 
 
These results also support the hypothesis that RV LRTI in infancy is a marker of underlying 
susceptibility to longer-term respiratory morbidity, rather than being a causative factor 24; 25. 
Those studies were conducted in term-born cohorts and the current study adds to the literature 
demonstrating an at-risk group (cluster three) within a cohort of prematurely-born infants. 
 
The strengths of this study include the relatively large cohort recruited, the detailed 
information regarding respiratory infections in the first year after birth and the length of the 
follow-up period.  A weakness of the study is the number of children in whom school age 
data could be obtained, meaning that the inferences about longer term outcomes between 
clusters are somewhat less robust than the prediction of LRTI risk.  We recognise the 
possibility of error introduced by the small numbers of individuals in clusters two and three at 
school age, but have shown a number of   significant differences between our three clusters at 
school age.  The main reason for non-participation was failure to respond to the invitation 
letters.  All surviving members of the original cohort were invited to participate, with a 
number of reminder invitations sent over the one-year period of recruitment.  The overall 
retention rate of 33%, however, was similar to that reported in other studies 26; 27. The 
retention rates within clusters were 32%, 30% and 63% for clusters one, two and three 
respectively.  It was fortunate that attrition was lower in the smallest of the three groups such 
that this group could be retained within the analysis.  The cohort of children whom we were 
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able to follow up were representative of the overall group, with the exception of a 
significantly lower birth weight and longer duration of supplemental oxygen in those children 
followed up in cluster two.  Our focus was on respiratory outcomes and we did not quantify 
other potential complications of prematurity such as neurodevelopmental abnormalities.  
Given the apparent higher non-respiratory healthcare costs within clusters two and three, it is 
possible that such consequences of premature birth were more pronounced within these two 
groups.  
 
In conclusion, our study provides evidence that readily available clinical variables can be 
used to effectively classify prematurely born infants into distinct groups.  Those groups were 
at varying degrees of risk for viral respiratory tract infections, and our data suggest that they 
had differing respiratory outcomes at school age.  These data can be applied on an individual 
basis and, therefore, may be of value to clinicians counselling parents as to the possible 
outcomes of preterm birth as well as researchers planning interventional studies.  
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LEGENDS 
 
Table legends 
Table 1: Baseline characteristics  
Table 2 Distribution of viral infection frequencies in the first year across clusters.  Data are 
presented as n (%). 
Table 3  Healthcare utilisation costs across clusters from one year of age to point of school 
age follow up.  Data are presented as mean (95% confidence intervals). 
 
Figure 1:  Decision metric, derived using conditional inference tree analysis, to allow 
classification of children into clusters based on a minimal subset of variables. 
 
Supplementary file legends 
 
Table 1:  Characteristics of participants who did and did not participate in the school  
 
age follow up study. 
 
Figure 1:  Cluster dendrogram showing a three-cluster solution.  The heights at which 
observations, or groups of observations, fuse indicate the degree of similarity.  The dashed 
line denotes the cut point used to derive the clustering solution.   
 
 
Figure 2: Discriminant projection plot of clustering solution.  Shaded areas are the 95% 
confidence regions for each cluster assuming elliptical clusters 
 
 
 

Table 1: Baseline characteristics  
Data are presented as n or median (IQR) 
 Cluster One Cluster Two Cluster Three P value 
across 
clusters 
n 140 20 8  
Sex (M : F) 80 : 60 12 : 8 4 : 4 0.89 
Gestational age (weeks) 34+2 
(32+6 to 35+2) 
29+1 
(28+2 to 31+2) 
24+5 
(23+6 to 26+3) 
<0.001 
Birth weight (g) 2042 
(1708 to 2372) 
1313 
(1060 to 1508) 
670 
(628 to 732) 
<0.001 
Duration of invasive 
mechanical ventilation (days) 
0 
(0 to 1) 
13 
(8 to 17) 
86 
(73 to 101) 
<0.001 
Duration of supplemental 
oxygen (days) 
0 
(0 to 1) 
23 
(10 to 52) 
119 
(99 to 257) 
<0.001 
Functional residual capacity (z 
scores) 
-0.67 
(-2.06 to 0.73) 
-2.13 
(-2.71 to -0.04) 
-5.12 
(-6.13 to -4.64) 
<0.001 
Respiratory system resistance 
(z scores) 
0.33 
(-0.15 to 1.11) 
1.18 
(0.57 to 2.70) 
2.41 
(0.94 to 4.06) 
0.009 
Respiratory system 
compliance (z scores) 
0.57 
(-0.05 to 1.14) 
-0.34 
(-0.59 to 0.59) 
-0.64 
(-1.09 to -0.20) 
<0.001 
  
 
Table 2 Distribution of viral infection frequencies in the first year across clusters.   
Data are presented as n (%). 
 
 Cluster one Cluster two Cluster three 
n 128 17 6 
LRTI in first year  62 (48%) 11 (65%) 6 
No LRTI (n (%)) 66 (51.6) 6 (35.3) 0 (0) 
RSV LRTI (n (%)) 21 (16.4) 7 (41.2) 1 (16.7) 
RV LRTI (n (%)) 15 (11.7) 1 (5.9) 4 (66.7) 
Other LRTI (n (%)) 26 (20.3) 3 (17.6) 1 (16.7) 
 
 
 
Table 3  Healthcare utilisation costs across clusters from one year of age to point of school 
age follow up.   
Data are presented as mean (95% confidence intervals). 
 
 Cluster One Cluster Two Cluster Three p value 
across 
clusters 
n 45 6 5  
Overall respiratory 
healthcare costs 
(£/year) 
110.54 
(29.17 to 
191.92) 
100.74 
(-65.46 to 
266.95) 
1575.05 
(2396.96 to 
5547.06) 
0.008 
Overall non-
respiratory healthcare 
costs (£/year) 
215.81 
(116.78 to 
314.84) 
950.68 
(70.07 to 
1831.28) 
1887.15 
(1326.83 to 
5101.14) 
0.003 
Respiratory related 
GP attendances 
(number/year) 
0.89 
(0.49 to 1.29) 
1.17 
(-0.38 to 2.71) 
3.20 
(0.24 to 6.16) 
0.014 
Non-respiratory 
related GP 
attendances 
(number/year) 
1.12 
(0.89 to 1.36) 
3.69 
(-1.24 to 8.61) 
2.02 
(0.70 to 3.34) 
0.089 
Respiratory 
medication costs 
(£/year) 
6.44 
(2.11 to 10.76) 
11.25 
(-6.76 to 29.25) 
31.21 
(-9.78 to 72.20) 
0.029 
Non-respiratory 
medication costs 
(£/year) 
22.44 
(1.35 to 43.52) 
20.74 
(-15.24 to 56.71) 
1068.87 
(-1859.95 to 
3997.69) 
0.289 
Respiratory related 
hospital costs (£/year) 
67.56 
(2.96 to 132.16) 
36.81 
(-57.81 to 
131.42) 
1405.58 
(-2419.43 to 
5230.69) 
0.030 
Non-respiratory 
related hospital costs 
(£/year) 
144.01 
(53.27 to 
234.75) 
767.76 
(-60.86 to 
1596.39) 
729.33 
(-9.53 to 
1468.20) 
0.002 
 
